Gastric Balloon in Turkey: 2026 Orbera vs Allurion Guide

Gastric balloons fill a specific niche in the weight loss spectrum: reversible, non-surgical, and suited to lower-BMI patients who do not qualify for sleeve or bypass. Here is what international patients should understand about brand choice, expected weight loss, tolerance, and the real price gap before booking treatment in Turkey.

The Reversible Bariatric Option: Why Gastric Balloons Are Different

Gastric balloons fill a specific niche in the weight loss spectrum. Unlike sleeve gastrectomy or gastric bypass, the procedure removes no tissue and reroutes no intestine. A silicone balloon is placed in the stomach (usually via endoscopy, sometimes swallowed), filled with saline, and removed after six or twelve months. The whole arrangement is reversible.

The mechanism is purely restrictive. The balloon occupies stomach volume, prompts earlier satiety, and slows gastric emptying. There is no metabolic component as with bypass. That makes the balloon better suited to lower-BMI patients (typically BMI 27 to 34) who do not qualify for, or do not want, surgical weight loss. It also serves as a pre-operative tool for patients with very high BMI who need to lose weight before a higher-risk bariatric surgery.

Mapa Health partners with Medistanbul Hospital, a central Istanbul facility with a dedicated bariatric program. The package covers pre-procedure blood work, endoscopic placement, hotel accommodation, six-month remote dietitian follow-up, VIP transfers, and 24/7 WhatsApp support.

Orbera vs Spatz3 vs Allurion: What the Evidence Shows

Three balloon systems dominate the global market. Orbera is the most widely used, a single silicone balloon filled with saline, removed after six months. Spatz3 is adjustable and stays in place for twelve months, allowing the balloon volume to be tuned to patient tolerance. Allurion (also called Elipse) is swallowed in a capsule rather than placed endoscopically and is naturally excreted after about sixteen weeks.

Published outcomes show meaningful differences. Orbera pooled total body weight loss is 12.3 percent at three months, 13.16 percent at six months, and 11.27 percent at twelve months (some weight typically returns after removal). Allurion delivers 14.1 percent total body weight loss on average within four months, with over 10 percent of patients losing more than 20 percent of body weight. Spatz3 produces sustained loss across twelve months but with a higher complication profile: published series report around 17 percent early removal rate, 6 percent serious events, and 4 percent gastric ulcers.

No single device is universally best. The right choice depends on patient anatomy, BMI, tolerance for endoscopy, and willingness to commit to twelve months versus six. Mapa Health's partner program offers both Orbera and Allurion options. The recommendation is made after the consultation based on BMI, prior bariatric history, and preference for endoscopic versus swallowable placement.

Weight Loss Outcomes and the Maintenance Challenge

Mapa Health cites typical outcomes of 15 to 25 kg over six to twelve months. The numbers are real but only half the story. Most published series confirm that the greatest weight loss occurs in the first three months, with up to 80 percent of the total achieved by month three.

The maintenance question is what separates the balloon from surgical bariatrics. Without lifestyle change, 50 to 70 percent of the lost weight typically returns after balloon removal. The body adapts to the missing volume restriction, hunger returns, and old eating patterns resume unless behavioural reshaping has taken hold during the balloon period. That is why structured nutritional follow-up matters more for balloon patients than for sleeve or bypass patients, where the anatomy provides ongoing physical restriction.

Mapa Health's six-month remote dietitian follow-up is built around this risk. The goal is not just weight loss during the balloon period but habit consolidation that survives removal. Patients who follow the dietitian protocol have a notably better five-year weight trajectory than those who treat the balloon as a stand-alone intervention.

Tolerance, Side Effects, and Early Removal Rates

The first three to seven days after placement are uncomfortable. Published series report that nausea, vomiting, and abdominal cramping affect 50 to 95 percent of patients in some form for several days. The body adapts, and most symptoms settle by the end of week one. Mapa Health's protocol includes 24/7 WhatsApp support during this window and antiemetic medication for symptom control.

The most common reason for early removal is intolerance: persistent symptoms that do not settle. Systematic reviews place early removal rates at 7.6 to 9.4 percent of patients, most often driven by nausea, reflux, epigastric pain, or persistent vomiting. Other complication rates from published data include abdominal pain in 15.6 percent of patients overall, gastroesophageal reflux in 12.5 percent, and nausea or vomiting peaking at 30.5 percent during the first weeks.

Rarer but serious complications include gastric ulcers (around 4 percent in Spatz3 series), balloon deflation (manageable but requires removal), and bowel obstruction if a deflated balloon passes into the intestine. These have driven FDA labelling updates and prompted device monitoring. Mapa Health's partner program follows the modern protocol with monitored placement and structured removal at the six or twelve month mark.

Cost in Turkey vs Western Europe and What to Verify Before Booking

Mapa Health's gastric balloon package starts at £3,550 and covers endoscopic placement, pre-procedure blood work and suitability checks, hotel accommodation, six-month remote dietitian follow-up, VIP transfers, and 24/7 WhatsApp support. The Istanbul market for gastric balloon packages typically runs $1,700 to $4,000, with an average around $2,800.

Western European pricing is comparatively close on the cheaper end, but the UK is notably higher. Orbera private placement in the UK averages around £4,300. Obalon is around £5,500. NHS gastric balloon (when available) sits at £3,000 to £5,000. Continental Europe pricing is less transparent, but the pattern of 50 to 70 percent savings for Turkey-based packages with hotel and follow-up included is consistent.

Before booking, ask five questions. First, which balloon brand is used (Orbera, Spatz3, Allurion) and why for your case. Second, what is the protocol for nausea and intolerance management in the first week. Third, what is the structure of dietitian follow-up: weekly check-ins, monthly, or ad hoc. Fourth, what is the cost and arrangement for balloon removal at six or twelve months (a return trip is usually required for endoscopic balloons). Fifth, what is the policy if early removal is needed due to intolerance. Mapa Health operates under registration AK-0456 oversight with a 4.5 of 108 Trustpilot score. Consult your doctor about whether the balloon suits your BMI category and weight loss goals, since surgical options may be more appropriate for higher BMI patients.